Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

NCT00019188 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Epidemic Kaposi's Sarcoma
Recurrent Kaposi's Sarcoma

Interventions

DRUG: interleukin-12

Sponsor

National Cancer Institute (NCI)